Cargando…
Intrathecal or Intraventricular Tigecycline Therapy for Central Nervous System Infection Associated with Carbapenem-Resistant Klebsiella pneumoniae
PURPOSE: Infection with carbapenem-resistant Klebsiella pneumoniae (CRKP) is a great challenge. Central nervous system (CNS) infection caused by CRKP is rarely reported, and effective treatment is limited. Thus, this study aimed to assess intrathecal (IT) or intraventricular (IVT) injection of tigec...
Autores principales: | Du, Ning, Mao, En-Qiang, Yang, Zhi-Tao, Qu, Hong-Ping, Qian, Xian, Shi, Ying, Bian, Xiao-Lan, He, Juan, Chen, Er-Zhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747839/ https://www.ncbi.nlm.nih.gov/pubmed/36533251 http://dx.doi.org/10.2147/IDR.S387346 |
Ejemplares similares
-
Intravenous plus intraventricular tigecycline-amikacin therapy for the treatment of carbapenem-resistant Klebsiella pneumoniae ventriculitis: A case report
por: Li, Jiyao, et al.
Publicado: (2022) -
Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae Due to In-Host Microevolution
por: Han, Xinhong, et al.
Publicado: (2021) -
Acquisition of Tigecycline Resistance by Carbapenem-Resistant Klebsiella pneumoniae Confers Collateral Hypersensitivity to Aminoglycosides
por: Chen, Hua-le, et al.
Publicado: (2021) -
Molecular epidemiology and mechanisms of tigecycline resistance in carbapenem‐resistant Klebsiella pneumoniae isolates
por: Park, Yumi, et al.
Publicado: (2020) -
Intrathecal tigecycline is a safe and effective treatment for central nervous system infections
por: Mastroianni, Antonio, et al.
Publicado: (2023)